RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Surgery Partners - Stock

Surgery Partners Stocks 2024

Surgery Partners Stocks

125.61 M

Ticker

SGRY

ISIN

US86881A1007

WKN

A14YWP

In 2024, Surgery Partners had 125.61 M outstanding stocks, a 0% change from the 125.61 M stocks in the previous year.

The Surgery Partners Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2027e125.61
2026e125.61
2025e125.61
2024e125.61
2023125.61
202292
202172.4
202048.8
201948.3
201848
201748.3
201648.2
201537.5
201448.2
201348.2
201248.2
201148.2

Surgery Partners shares outstanding

The number of shares was Surgery Partners in 2023 — This indicates how many shares 125.613 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Surgery Partners earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Surgery Partners's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Surgery Partners’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Surgery Partners's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Surgery Partners Aktienanalyse

What does Surgery Partners do?

Surgery Partners Inc is an American company specializing in specialized surgical services in the United States. It was founded in 1997 and is headquartered in Nashville, Tennessee. The company focuses on outpatient surgical procedures, providing a variety of medical services including eye surgery, endoscopy, ENT surgery, gynecology, orthopedic surgery, plastic surgery, and urology. Surgery Partners has over 180 surgical centers and practices in 32 states. It expanded its services through the acquisition of Symbion Healthcare in 2017, offering anesthesia services, pain management, diagnostics, and laboratory services. The company also emphasizes excellent service and has partnerships with hospitals to expand its surgical services. Surgery Partners ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Surgery Partners's Shares Outstanding

Surgery Partners's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Surgery Partners’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Surgery Partners’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Surgery Partners’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Surgery Partners Stock

How many stocks are there of Surgery Partners?

The current number of stocks of Surgery Partners is 125.61 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Surgery Partners are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Surgery Partners evolved in recent years?

The number of shares of Surgery Partners has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Surgery Partners as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Surgery Partners?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Surgery Partners pay?

Over the past 12 months, Surgery Partners paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surgery Partners is expected to pay a dividend of 0 USD.

What is the dividend yield of Surgery Partners?

The current dividend yield of Surgery Partners is .

When does Surgery Partners pay dividends?

Surgery Partners pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Surgery Partners?

Surgery Partners paid dividends every year for the past 0 years.

What is the dividend of Surgery Partners?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Surgery Partners located?

Surgery Partners is assigned to the 'Health' sector.

Wann musste ich die Aktien von Surgery Partners kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Surgery Partners from 7/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.

When did Surgery Partners pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of Surgery Partners in the year 2023?

In the year 2023, Surgery Partners distributed 0 USD as dividends.

In which currency does Surgery Partners pay out the dividend?

The dividends of Surgery Partners are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Surgery Partners stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Surgery Partners

Our stock analysis for Surgery Partners Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgery Partners Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.